The market is segmented based on , By Type (Vitamin K1 and Vitamin K2), Application (Osteoporosis, Vitamin-K Dependent Clotting Factor Deficiency [VKCFD], Dermal Applications, Prothrombin Deficiency, and Vitamin K Deficiency Bleeding [VKDB]), Route of Administration (Oral, Topical and Parenteral), and Mode of Consumption (Pills, Powders, Creams, and Liquids) – Industry Trends and Forecast to 2032.
.
The Global Vitamin K Market size was valued at USD 959.80 USD Billion in 2024.
The Global Vitamin K Market is projected to grow at a CAGR of 6.8% during the forecast period of 2025 to 2032.
The major players operating in the market include DSM , BASF SE , Lonza Group , Glanbia Plc , ADM , Farbest Brands , SternVitamin GmbH &, Co. K.G. , Adisseo , BTSA Biotechnologias Aplicadas S.L. , Rabar Pty Ltd , Kappa Bioscience AS, Viridis BioPharma , GeneFerm Biotechnology Co.Ltd. , Goodscend Pharm. Sci &, Tech. CoLtd , SEEBIO BIOTECH CO.Ltd. .
The market report covers data from the North America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.